Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06136598
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-10
First Post:
2023-11-13
Brief Title:
A Study of Opevesostat MK-5684 in China Participants With Metastatic Castration-Resistant Prostate Cancer mCRPC MK-5684-001
Sponsor:
Organization:
Merck Sharp Dohme LLC